Completed Equality Screenings - Quarter 2 - July 2012 - September 2012
Date published:
In fulfilling the commitments within its Equality Scheme the Department equality screens policies to assess the impact and determine if a full Equality Impact Assessment (EQIA) is required.
Documents
- A 10 year Quality Strategy for Health and Social Care in Northern Ireland
- A Review of the HSC Student Bursary Schemes 2012
- Learning Disability Service Framework
- NICE CG 141 Acute Upper Gastrointestinal Bleeding
- NICE CG 142 Autistic Spectrum Conditions in Adults
- NICE CG 143 Sickle Cell Acute Painful Episode
- NICE CG 144 Venous Thromboembolic Diseases
- NICE CG 145 - Spasticity in Children and Young People
- NICE CG 146 Osteoporosis: assessing the risk of fragility fracture
- NICE CG 147 Lower limb peripheral arterial disease
- NICE CG 148 Urinary incontinence in neurological disease
- NICE TA 261 Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
- NICE TA 263 Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
- Revised arrangements for Pre-Registration pharmacy trainees in Northern Ireland